Fact.MR – A Market Research and Competitive Intelligence Provider: As per latest Fact.MR analysis, the global vocal biomarker market is anticipated to rise at a stellar CAGR of around 23.3% during the forecast period of 2018 and 2027.
Vocal Biomarker to Remain a Key Tool for Early Detection of Psychological and Cardiovascular Disorders
Fact.MR’s latest report offers actionable and valuable insights into the vocal biomarker market. It sheds light on vital dynamics such as drivers, restraints, opportunities and emerging trends shaping the market growth across key regions. To present in-depth analysis of the market overview, the report has been segmented in terms of indication, technique, region and end user.
Fact.MR – A Market Research and Competitive Intelligence Provider: As per latest Fact.MR analysis, the global vocal biomarker market is anticipated to rise at a stellar CAGR of around 23.3% during the forecast period of 2018 and 2027. With rising need for early diagnosis of many psychiatric and cardiovascular disorders, sales of biomarkers are expected to surpass US$ 390 by the end of 2027.
Increasing prevalence of chronic disorders, growing trend of remote monitoring, and rising adoption of vocal biomarkers for assessing multiple disorders are some of the factors driving the vocal biomarker market.
Vocal biomarkers are being extensively used in the early diagnosis of various diseases by means of analyzing speech features in a non-invasive manner. The vocal biomarker technology is based on the idea that severe disorders impact motor control and hence modify speech output.
Surge in mental disorders such as depression, anxiety, and others has become a serious concern across the globe. Proper diagnosis of these mental diseases is crucial for initiating the treatment procedures. As a result, demand for diagnostic technologies such as vocal biomarker is on the rise.
According to the World Health Organization (WHO), an estimated 264 million people are affected by depression worldwide. This is positively impacting the vocal biomarkers market.
Advanced technologies such as artificial intelligence (AI) and internet of things (IoT) are integrated for developing remote screening and monitoring solutions. Consecutively, huge investments are being directed towards developing new vocal biomarkers.
For More Valuable Information on Market Dynamics, Request a Report Sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=719
For instance, in August 2021, Kintsugi, a Berkeley-based start AI startup, secured US$8 Mn from investors to build out voice biomarker-based mental health tech.
Regionally, North America will continue to remain the hub for vocal biomarkers, owing to the increasing prevalence of psychological and cardiovascular disorders, availability of advanced biomarker systems, and surging demand for minimally invasive diagnostic procedures.
“Amid growing popularity of vocal biomarkers, market players are launching new virtual platforms for detecting multiple disorders. This will create a conducive environment for the global vocal biomarker market. Besides this, gradual penetration of vocal biomarkers in emerging economies will also bode well for the market,” says a Fact.MR analyst
Key Takeaways from Vocal Biomarker Market Survey
- North America is likely to capture a commendable share of the global vocal biomarker market.
- Europe will exhibit strong growth on the back of expanding psychiatrist clinics, presence of leading players, and advancement in medical technology across the U.K. and Germany.
- With increasing prevalence of cardiovascular and psychological disorders and rising government support, Asia is expected to emerge as a lucrative market for vocal biomarkers.
- By indication, psychiatric disorders segment is expected to dominate the vocal biomarker market.
- Hospitals & clinics segment will emerge as the primary end user in the global vocal biomarker market.
Key Drivers
- Increasing prevalence of psychological and cardiovascular disorders worldwide is driving the vocal biomarker market.
- Rising need for minimally invasive procedures for diagnosis of various disorders will continue to fuel the demand for vocal biomarkers.
- Low cost, easy availability, and growing awareness regarding the importance of vocal biomarkers will aid the growth in the market during the forecast period.
- Emergence of advanced vocal biomarker screening platforms will facilitate the growth in the market.
Key Restraints
- Lack of awareness in some low- and middle- income regions is restraining the growth of the market.
For Critical Insights on the Vocal Biomarker Market, Request for Methodology here
https://www.factmr.com/connectus/sample?flag=RM&rep_id=719
Competitive Landscape
Leading players operating in the vocal biomarker market are investing heavily in research and development activities. They are adopting various growth strategies such as partnerships, advanced product development and collaborations. Besides this, they are launching various awareness campaigns to penetrate attractive markets.
- In October 2021, Sonde Health unveiled Sonde Mental Fitness, a voice-enabled mental health detection and monitoring technology that uses a brief voice sample to evaluate mental well-being. Available as an application programming interface (API) for health systems, employers, and wellness service providers, Sonde Mental Fitness is an easy and affordable way for individuals to engage with and better understand their mental well-being and can serve as a much-needed early warning system for depression and other mental health conditions.
- In August 2021, Cigna International announced the launch of the Cigna StressWaves Test, a free online tool that analyses acoustic and semantic voice patterns to evaluate stress levels. The StressWaves Test was created in partnership with Ellipsis Health, a medical technology developer and leader in AI health and vocal biomarkers. The test will reveal the user's stress level, ranging from 'Extremely Stressed' to 'No Stress', along with a portrait that visualizes the effect of stress on the user's body and mind.
- In December 2019, Beyond Verbal and Healthymize, two early-stage Israeli AI healthtech companies, announced a merger to create a joint company that will be a global leader in vocal biomarkers. The new company, to be called Vocalis Health, will be based in Newton, MA and Israel, and will receive a US $9 million investment from a syndicate of funds led by aMoon, Israel's largest healthtech and life sciences fund.
Some of the prominent players operating in the vocal biomarker market profiled by Fact.MR are:
- Beyond Verbal, Inc.
- Sonde Health Inc.
- Sharecare, Inc.
- IBM Corporation
- Cogito Corporation
- Others
More Insights on the Global Vocal Biomarker Sales Outlook
Fact.MR provides an unbiased analysis of vocal biomarker market, presenting historical demand data (2013-202017) and forecast statistics for the period from 2018-2027. The study divulges compelling insights on the global demand for vocal biomarker with a detailed segmentation on the basis of:
Region
- North America
- Latin America
- Europe
- Japan
- APEJ
- MEA
Technique
- Frequency
- Amplitude
- Error Rate
- Vocal Rise or Fall Time
- Phonation Time
- Voice Tremor
- Pitch
- Other Types
End User
- Hospitals & Clinics
- CROs
- Academic and Research Center
- Other End User
Indication
- Psychiatric Disorders
- Respiratory Disorders
- Cardiovascular Disorders
- Traumatic Brain Injury (TBI)
- Neurological Disorders
- Other Disorder
Key Questions Covered in the Vocal Biomarker Market Outlook Report
- The report offers insight into vocal biomarker demand outlook for 2018-2027
- The market study also highlights projected sales growth for vocal biomarker market between 2018 and 2027
- Vocal biomarker market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
- Vocal biomarker market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others
Explore Fact.MR’s Coverage on the Healthcare Domain –
Biomarker Detection Systems Market Scope - Around the world, cardiovascular disorders, cancer, and neurological diseases are on the rise. Biomarker detection technologies have resulted as a result of this. Biomarkers are used to examine the formation of superfluous tissues and the damage to good tissues in such circumstances. This aids clinicians in determining the problem, disease stage, and drug to be prescribed to the patient. People prefer quick treatment over delayed treatment because cancer is the leading cause of death worldwide. Thus, biomarkers are commonly employed for cancer patients since they detect tissue growth at an early stage.
Tuberculosis Biomarkers Market Insights - The market for tuberculosis biomarkers is primarily driven by important factors such as rising tuberculosis incidence. New tuberculosis biomarkers are likely to play a critical role in assisting scientists in characterizing and selecting appropriate treatment regimens. The Tuberculosis biomarkers market is predicted to develop due to significant advancements in antigen detection technology and biomarker discovery methodologies. In poorer nations, raising awareness among doctors, patients, and technicians would aid in market expansion.
Cancer Biomarkers Market Forecast - The rising incidence of cancer has permitted substantial cancer research in terms of diagnosis and treatment. Clinical trials are increasingly being funded by governments to aid corporations in developing effective cancer diagnosis and treatments. Governments' aggressive funding initiatives for cancer diagnostics are expanding the market for cancer biomarkers. Demand for cancer biomarkers will be bolstered by factors such as the availability of low-cost, non-invasive prognosis.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to chemical and materials, technology to even the most niche categories. 80% of Fortune 1000's trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our chemical and materials research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR